A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection

Clinical trial NCT00001443 · COMPLETED

Trial details

NCT number: NCT00001443
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome HIV Infections

Start date: 1995-07-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.